REGENERON PHARMACEUTICALS INC. - COMMON STOCK

NetDania - New 12 months Low: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

04 фев 2025 08:45:06 Источник NetDania Notify

Regeneron Reports Fourth Quarter and Full Year 2024 Financial and Operating Results; Initiates Quarterly Dividend and Increases Total Share Repurchase Capacity to ~$4.5 Billion

04 фев 2025 05:30:01 Источник Nasdaq GlobeNewswire

NetDania - New 12 months Low: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

03 фев 2025 08:46:44 Источник NetDania Notify

America’s Top 40 High School Scientists to Compete for $1.8 Million in Awards at Prestigious Regeneron Science Talent Search

23 янв 2025 11:00:14 Источник Nasdaq GlobeNewswire

NetDania - New 12 months Low: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

13 янв 2025 08:45:01 Источник NetDania Notify

Regeneron Provides Business Updates and Highlights from Broad Clinical Pipeline at the 43rd Annual J.P. Morgan Healthcare Conference

13 янв 2025 05:30:00 Источник Nasdaq GlobeNewswire

Adjuvant Libtayo® (cemiplimab) Significantly Improves Disease-Free Survival (DFS) After Surgery in High-Risk Cutaneous Squamous Cell Carcinoma (CSCC) in Phase 3 Trial

13 янв 2025 05:15:45 Источник Nasdaq GlobeNewswire

Regeneron Collaborates with Truveta and Leading American Health Systems to Massively Extend its DNA Sequence-Linked Healthcare Database to Further Advance Scientific Innovation and Healthcare Delivery

13 янв 2025 05:05:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months Low: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

10 янв 2025 11:29:29 Источник NetDania Notify

Regeneron to Report Fourth Quarter and Full Year 2024 Financial and Operating Results and Host Conference Call and Webcast on February 4, 2025

07 янв 2025 15:05:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months Low: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

19 дек 2024 08:45:02 Источник NetDania Notify

Regeneron to Advance Two Factor XI Antibodies into a Broad Phase 3 Program Following Positive Phase 2 Proof-of-concept Results

19 дек 2024 06:00:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months Low: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

18 дек 2024 14:08:04 Источник NetDania Notify

Regeneron Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference

17 дек 2024 15:05:00 Источник Nasdaq GlobeNewswire

NetDania - New 12 months Low: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

17 дек 2024 08:45:01 Источник NetDania Notify

EYLEA HD® (aflibercept) Injection 8 mg Phase 3 Trial Meets Primary Endpoint Showing Improved Vision with Extended Dosing Intervals in Patients with Macular Edema following Retinal Vein Occlusion

17 дек 2024 06:00:00 Источник Nasdaq GlobeNewswire

Regeneron Named to Dow Jones Sustainability World Index for Sixth Consecutive Year

16 дек 2024 15:30:25 Источник Nasdaq GlobeNewswire

NetDania - New 12 months Low: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

16 дек 2024 08:45:56 Источник NetDania Notify

NetDania - New 12 months Low: REGENERON PHARMACEUTICALS INC. - COMMON STOCK

13 дек 2024 08:46:56 Источник NetDania Notify

Odronextamab ASH Presentations Underscore Impressive Potential in Earlier Lines of Treatment and Additional Types of Lymphoma

09 дек 2024 16:45:23 Источник Nasdaq GlobeNewswire